SCHEMBL14728237

SCHEMBL14728237

CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TSHR P16473 5/20 0.50
FFAR3 O14843 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
THRB P10828 1/20 0.43
AKR1B1 P15121 1/20 0.39
LMNA P02545 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
HSD17B10 Q99714 2/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
PPARG P37231 6/20 0.37
PPARD Q03181 6/20 0.37
PPARA Q07869 6/20 0.37
HDAC11 Q96DB2 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389884 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL17418301 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL19382679 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL16908570 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL2944700 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL14770377 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL22445118 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL22445105 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL21087133 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1
SCHEMBL29649576 1.00 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130052130-A1 Branched Discreet PEG Constructs UNIVERSITY OF WASHINGTON (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130052130-A1 Branched Discreet PEG Constructs BTD, DNPEP, IDUA ALDH1A1 1014/4885TSHR 1649/4885FFAR3 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.